Yale Medicine School: Resistance to Antimalarial Drugs Measured, Mapped by YSPH Researchers
July 17, 2021
July 17, 2021
NEW HAVEN, Connecticut, July 17 (TNSJou) -- Yale School of Medicine issued the following news:
Despite major progress in the global fight to end malaria, the parasite responsible for the disease has evolved resistance to every antimalarial drug deployed to date.
Experts have long worried about the emergence of drug resistance to the current frontline treatment in Africa, a region that accounts for the overwhelming majority of malaria cases and deaths. The top-line drugs . . .
Despite major progress in the global fight to end malaria, the parasite responsible for the disease has evolved resistance to every antimalarial drug deployed to date.
Experts have long worried about the emergence of drug resistance to the current frontline treatment in Africa, a region that accounts for the overwhelming majority of malaria cases and deaths. The top-line drugs . . .